TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional short-term treatments. The therapy may replace bladder removal surgery for many and has earned FDA Priority Review due to its impressive results.
source https://www.sciencedaily.com/releases/2025/11/251111010000.htm
The COVID‑19 pandemic exposed the load mothers carry—a burden that's still
being ignored today
-
The COVID-19 pandemic exacerbated and brought into focus the ongoing
disproportionate burden on mothers when it comes to household logistics,
child care an...
2 days ago
No comments:
Post a Comment